Scanning electromicrograph of an HIV-infected T cell. Credit: NIAID Researchers can now quickly and accurately count a hidden, inactive form of the human immunodeficiency virus (HIV) that lurks in patients’ cells. This version of HIV embeds into cells’ genomes and can persist despite otherwise successful therapies—thwarting attempts to cure the infection. Using a new genetic […]Continue Reading ...
In the current issue of Cardiovascular Innovations and Applications (Special Issue on Stable Ischemic Heart Disease, Volume 3,Number 3, 2019, pp. 317-319(3); DOI: https://doi.org/10.15212/CVIA.2016.0007 C. Richard Conti from the University of Florida Medical School, Gainesville, FL, USA considers sudden cardiac death in adult patients with stable ischemic heart disease. Sudden death in patients with stable […]Continue Reading ...
Study by the University of Bonn shows that patients survive significantly longer with combination chemotherapy Cancer researchers at the University of Bonn have reported significant progress in the treatment of glioblastoma. About one third of all patients suffer from a particular variant of this most common and aggressive brain tumor. Survival of these patients treated […]Continue Reading ...
Study could help identify patients with glioblastoma who are most likely to respond to immunotherapy. Columbia researchers have learned why some glioblastomas–the most common type of brain cancer–respond to immunotherapy. The findings could help identify patients who are most likely to benefit from treatment with immunotherapy drugs and lead to the development of more broadly […]Continue Reading ...
The artificial intelligence software, created by researchers at Imperial College London and the University of Melbourne, has been able to predict the prognosis of patients with ovarian cancer more accurately than current methods. It can also predict what treatment would be most effective for patients following diagnosis. The trial, published in Nature Communications took place […]Continue Reading ...
Lancaster University is sharing in a €4m project to use gaming technology to improve the care of both adults and children with cancer. The project – called “MyPal: Fostering Palliative Care of Adults and Children with Cancer through Advanced Patient Reported Outcome Systems” funded by EU Horizon 2020, has 16 partners in seven countries. It […]Continue Reading ...
Responding to the release of performance figures for January 2019 which show worst ever four-hour performance and the highest ever number of emergency admissions, President of the Royal College of Emergency Medicine, Dr Taj Hassan said: These are the worst figures on record, showing that despite the positivity around the NHS Long Term Plan, the […]Continue Reading ...
JERSEY CITY, N.J., Jan. 30, 2019 /PRNewswire/ — Scynexis, Inc. (NASDAQ: SCYX), a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, today announced positive results from the first interim efficacy analysis of the ongoing FURI study. FURI is a Phase 3 open-label study evaluating oral ibrexafungerp as a salvage treatment in patients […]Continue Reading ...
A new study indicates that both high-grade abnormal cellular changes (dysplasia) and esophageal adenocarcinoma (a form of cancer) have increased in the last 25 years among people with a digestive condition known as Barrett’s esophagus. The study report, Increasing prevalence of high-grade dysplasia and adenocarcinoma on index endoscopy in Barrett’s esophagus over the past 2 […]Continue Reading ...
A new software tool has proved to be four times more reliable than current methods at predicting prognosis in patients with ovarian cancer. The tool was also able to predict the most effective course of treatment for patients once they had been diagnosed. Fancy Studio | Shutterstock Ovarian cancer is the sixth common cancer in […]Continue Reading ...
FOSTER CITY, Calif.–(BUSINESS WIRE)–Feb. 11, 2019– Gilead Sciences, Inc. (Nasdaq: GILD) today announced that STELLAR-4, a Phase 3, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of selonsertib, an investigational, once-daily, oral inhibitor of apoptosis signal-regulating kinase 1 (ASK1), in patients with compensated cirrhosis (F4) due to nonalcoholic steatohepatitis (NASH), did not meet the […]Continue Reading ...
A new technique using patients’ own modified cells to treat Crohn’s disease has been proven to be effective in experiments using human cells, with a clinical trial of the treatment expected to start in the next six months. Researchers at the NIHR Guy’s and St Thomas’ Biomedical Research Centre (BRC) developed the technique by studying […]Continue Reading ...
Patients with Parkinson’s disease are known to have abnormal brain waves especially beta waves in their subthalamaic nucleus (STN) region of the brain. Until now there have been no studies that connect these abnormal beta waves or “β-band oscillation” and the movement difficulties typically seen with Parkinson’s disease. Authors write, “Previous studies demonstrated that l-DOPA […]Continue Reading ...
Two checkpoint inhibitors provide early encouraging results for immunologically cold disease Some patients with metastatic prostate cancer respond to a combination of immune checkpoint inhibitors after hormonal therapy and chemotherapy have failed, according to early results from a clinical trial led by investigators at The University of Texas MD Anderson Cancer Center presented today at […]Continue Reading ...
A lot of patients with arteries clogged by cholesterol aren’t taking their statins, Stanford researchers have found. That boosts their risk of death, according to a new study. More than a third of patients with cardiovascular disease who have been prescribed statins to reduce cholesterol failed to take them daily, according to a review of […]Continue Reading ...
- Customized Micropatterning for Improved Physiological Relevance
- Unique gene therapy approach paves new way to tackle rare, inherited diseases
- Activating gene that helps excite neurons reverses depression in male mice
- Science Puzzling Out Differences in Gut Bacteria Around the World
- Cells that destroy the intestine
- On recovery, vulnerability and ritual: An exhibit in white
- Scientific Duo Gets Back To Basics To Make Childbirth Safer
- COPD patients need more support when understanding new chest symptoms
- Using light-based method for production of pharmaceutical molecules
- Scientists find link between inflammation and cancer
- The High Cost Of Sex: Insurers Often Don’t Pay For Drugs To Treat Problems
- Hearing impairment associated with accelerated cognitive decline with age
- Researchers identify multiple genetic variants associated with body fat distribution
- Influenza and common cold are completely different diseases, study shows
- Scientists untangle how microbes manufacture key antibiotic compound
- Greater primary care physician supply associated with longer life spans
- HIV-1 protein suppresses immune response more broadly than thought
- For 2020 Dem Hopefuls, ‘Medicare-For-All’ Is A Defining Issue, However They Define It
- KU professor discusses promise of brain-computer interface to aid, restore communication
- Highly effective solution for detecting onset of aggregation in nanoparticles